The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Net Asset Value(s)

24 Dec 2021 10:27

RNS Number : 7785W
Baillie Gifford European Growth Tst
24 December 2021
 

Baillie Gifford European Growth Trust plc (BGEU)

23 December 2021

Legal Entity Identifier : 213800QNN9EHZ4SC1R12

 

 

Cum Par NAV

153.50p

 

 

 

 

Cum Fair NAV

153.59p

 

 

 

 

Ex Par NAV

153.01p

 

 

 

 

Ex Fair NAV

153.10p

 

 

 

 

 

 

 

The fair value of long term borrowings is calculated weekly, using methodologies consistent with the International Private Equity and Venture Capital Valuation (IPEV) Guidelines.

 

 

 

 

 

Short-term borrowings are valued at par.

 

 

 

 

 

Net Asset Values are unaudited, and calculated in accordance with published accounting policies and AIC guidelines.

 

 

 

 

 

Cum Par NAV: Net asset value per share in pence, including income, with debt at par value.

 

 

Cum Fair NAV: Net asset value per share in pence, including income, with debt at fair value.

 

 

Ex Par NAV: Net asset value per share in pence, excluding income, with debt at par value.

 

 

Ex Fair NAV: Net asset value per share in pence, excluding income, with debt at fair value.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVPPGQPPUPGGUC

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.